BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intellect Neurosciences, Inc. 

7 West 18th Street
9th Floor
New York  New York  10011  U.S.A.
Phone: 212-448-9300 Fax: 212-448-9600


SEARCH JOBS










 Company News
Intellect Neurosciences, Inc. Obtains Patent Allowance From The United States Patent And Trademark Office In Relation To Its TOC-1 Monoclonal Antibody Selective For Pre-Fibrillar Tau Aggregates 11/14/2013 1:26:16 PM    More...
Intellect Neurosciences, Inc. Issues Letter to Shareholders 6/20/2013 8:56:40 AM    More...
Intellect Neurosciences, Inc. Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value 6/19/2013 9:44:25 AM    More...
Intellect Neurosciences, Inc. Issues Letter to Shareholders 3/29/2013 10:19:53 AM    More...
Intellect Neurosciences, Inc. CEO Daniel Chain Provides Conference Highlights of Alzheimer's Drug Development Summit in Neurotech Insights Magazine 1/2/2013 9:24:04 AM    More...
Intellect Neurosciences, Inc. Issues Letter to Shareholders 10/16/2012 9:36:34 AM    More...
Intellect Neurosciences, Inc. Files Lawsuit Against Pharmaceutical Licensee for Non Payment of $2 Million Milestone 10/15/2012 9:36:41 AM    More...
Intellect Neurosciences, Inc. and iNovacia Enter Research Service Agreement to Evaluate Lead Compounds for CONJUMAB-A Program 10/3/2012 9:36:19 AM    More...
Intellect Neurosciences, Inc. and Medical Research Council Technology Announce Humanization of Next-Generation Monoclonal Antibody to Amyloid Beta With Reduced Potential for Inflammation in the Brain of Alzheimer's Patients 9/19/2012 9:19:58 AM    More...
Intellect Neurosciences, Inc. Issues Letter to Shareholders 8/8/2012 10:02:40 AM    More...
12345678